
Crespine Gel Plus
Crespine Gel Plus is an advanced intraarticular injection designed to provide effective relief for patients suffering from osteoarthritis pain. With its innovative double cross-linked hyaluronic acid formula and incorporation of Prilocaine, this medical device stands out as a groundbreaking solution for joint health.
Crespine Gel Plus: Revolutionary Relief for Osteoarthritis
Explore the benefits of Crespine Gel Plus today and take the first step toward pain-free movement.
Crespine Gel Plus is a cutting-edge intraarticular injection developed to provide effective and lasting relief for individuals suffering from osteoarthritis pain. Its innovative formula combines double cross-linked hyaluronic acid with Prilocaine, offering a groundbreaking approach to joint health management.
Designed as a single-injection treatment, Crespine Gel Plus delivers long-term benefits by lubricating and cushioning the joints, reducing pain, and enhancing mobility. This trusted and advanced medical solution provides patients with a safer and more effective alternative to traditional therapies, paving the way for improved joint health and a better quality of life.
Key Benefits of Crespine Gel Plus
1. Single Injection Solution
Crespine Gel Plus requires only a single injection for lasting relief, reducing the need for multiple visits to the clinic. This approach minimizes the risk of infection, enhances patient compliance, and makes the treatment both time-efficient and cost-effective.
2. Long-Lasting Relief
The double cross-linked hyaluronic acid formula ensures prolonged effectiveness, providing lubrication and cushioning for joints for up to 12 months. This reduces pain and enhances mobility, allowing patients to maintain their daily activities with ease.
3. Non-Animal Origin
Made from non-animal sources, Crespine Gel Plus eliminates ethical concerns and reduces the risk of allergic reactions. Its biocompatibility ensures safety and excellent tolerability for all patients.
4. Delays the Need for Surgery
By alleviating osteoarthritis pain and supporting joint function, Crespine Gel Plus helps delay invasive surgical procedures. This gives patients more time to explore conservative treatments and maintain their natural joint health.
5. Innovative Combination of HA and Prilocaine
Crespine Gel Plus is the first patented medical device combining hyaluronic acid and Prilocaine. This unique combination ensures a painless application and extended effectiveness at the injection site.
6. Targeted and Local Treatment
The injection is administered directly into the affected joint space, providing localized pain relief and joint lubrication. This site-specific approach minimizes systemic side effects and enhances treatment outcomes.
Ideal Use Cases
Crespine Gel Plus is specifically recommended for:
- Patients with mild to moderate osteoarthritis.
- Individuals intolerant to long-term use of NSAIDs or allergic to other pain relief medications.
- Those seeking a minimally invasive solution to manage osteoarthritis symptoms effectively.
Advanced Technology for Superior Performance
The manufacturing process of Crespine Gel Plus ensures a stable and long-lasting product:
- Double Cross-Linking Technology: Extends the duration of hyaluronic acid in the joint, maintaining its effectiveness.
- Outer and Inner Core Design: The outer layer provides immediate lubrication, while the inner core acts as a reservoir, protecting the hyaluronic acid from enzymatic degradation.
Why Choose Crespine Gel Plus?
- Certified Safety: Registered with the EU and meets international standards for medical devices.
- No Side Effects: Demonstrated excellent tolerability in clinical use.
- Cost-Effective: A single injection provides year-long relief, reducing overall treatment costs.
- Scientifically Backed: Supported by research showcasing its unique 3D structure and sustained effectiveness.
| Weight | 135 g |
|---|---|
| Dimensions | 200 × 90 × 20 mm |
| Dosage | Recommended Dose: |
| Instructions | Preparation: Ensure the injection site is properly disinfected. Administration: Inject directly into the synovial space of the affected joint using the pre-filled syringe provided. Post-Injection Care: Advise the patient to rest the treated joint for 24-48 hours. Storage: Store the product between 2°C to 25°C (36°F to 77°F). Precautions: Do not inject into infected or inflamed joints. |
| Content | Single Injection Treatment 2.0ml |

